Longboard has commenced the Phase III DEEp OCEAN Study of bexicaserin for treating seizures linked to DEEs in two years and ...
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...
Syros noted that SELCT-MDS-1 Phase III trial’s failure to meet its endpoint constituted a default event under its secured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback